Uzuwet Tablet

About

Uzuwet Tablet contains Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid. This medication works by reducing the synthesis and secretion of cholesterol in the liver, thereby decreasing the cholesterol content of bile. This action helps to dissolve cholesterol gallstones and prevents their formation. Additionally, UDCA has cytoprotective and immunomodulatory properties, making it beneficial in various cholestatic liver diseases, such as primary biliary cholangitis (PBC). By improving bile flow and protecting liver cells from toxic bile acids, Uzuwet helps to alleviate symptoms and slow the progression of these conditions, enhancing liver function and overall patient well-being. It is a cornerstone therapy for specific hepatobiliary disorders.

Uses

• Dissolution of small to medium-sized cholesterol gallstones
• Primary biliary cholangitis (PBC)
• Cholestatic liver diseases
• Prevention of gallstone formation in certain conditions

Directions For Use

Taken orally, usually with food, as prescribed by a doctor. Dosage varies based on the specific condition being treated and patient response.

Benefits

• Effectively dissolves cholesterol gallstones
• Improves liver function in primary biliary cholangitis
• Reduces symptoms associated with cholestasis
• Prevents the formation of new gallstones
• Protects liver cells from toxic bile acids
• Aids in improving bile flow and digestion

Side Effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Constipation
• Dyspepsia
• Rash
• Pruritus
• Hair thinning
• Dizziness
• Fatigue

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can worsen liver conditions and potentially reduce treatment efficacy.
• Pregnancy - Use with caution; limited data available. Only if clearly needed and benefits outweigh potential risks.
• Breastfeeding - Considered safe; minimal excretion into breast milk. Monitor infant for any unusual symptoms.
• Liver - Primary indication for liver conditions; monitor liver function tests regularly during treatment.
• Kidney - No specific dose adjustment is typically needed for renal impairment.
• Lung - No specific contraindication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.